MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Ownership - Who Owns MoonLake Immunotherapeutics?

85 Followers

MoonLake Immunotherapeutics (MLTX) Ownership Overview

The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail and individual investors. Approximately 92.28% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 7.72% is owned by Public Companies and Individual Investors.
0.00% Owned by Insiders
13.75% Owned by Mutual Funds
78.53% Owned by Other Institutional Investors
7.72% Owned by Public Companies and Individual Investors

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 10, 2023
Chen Bihua
>10% Owner
Bought$3523868
Oct 04, 2023
Chen Bihua
>10% Owner
Bought$16799445
Jun 28, 2023
Chen Bihua
>10% Owner
Bought$20535012
Mar 22, 2023
Chen Bihua
>10% Owner
Bought$16772468

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2023Bought$767397
Jun 30, 2023Bought$2523429

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,136,951Institution2.13%65,238,248
937,839Institution1.75%53,813,202
864,623Institution1.62%49,612,068
682,871Institution1.28%39,183,138
677,330Institution1.27%38,865,195
583,000Institution1.09%33,452,540
398,062Institution0.74%22,840,798
381,585Institution0.71%21,895,347
325,135Institution0.61%18,656,246
249,495Institution0.47%14,316,023

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,136,951Institution2.13%65,238,248
937,839Institution1.75%53,813,202
864,623Institution1.62%49,612,068
682,871Institution1.28%39,183,138
677,330Institution1.27%38,865,195
583,000Institution1.09%33,452,540
398,062Institution0.74%22,840,798
381,585Institution0.71%21,895,347
325,135Institution0.61%18,656,246
213,700Institution0.40%12,262,106

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
168,380Institution0.31%9,661,644
81,115Institution0.15%4,654,379
11,783Institution0.02%678,347
12,748Institution0.02%670,417
9,576Institution0.02%503,602
7,676Institution0.01%419,647
6,715Institution0.01%386,583
5,855Institution0.01%320,093
3,889Institution<0.01%235,401
3,687Institution<0.01%201,568

FAQ

Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 78.53% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 7.72% is held by retail investors.
    What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 78.53% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
      What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.72% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
        Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
        Federated Hermes Equity Funds owns the most shares of MoonLake Immunotherapeutics (MLTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis